Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis (COMBAT)
Endovascular Treatment of Atherosclerotic Renal Artery Stenosis: A Prospective Randomized Controlled Study Comparing Covered Stents and Bare Metal Stents
Atherosclerotic renal artery stenosis is the most common cause of secondary hypertension , increasing the risk of cardiovascular and kidney-related complications. Some small-scale studies have suggested that covered stents are effective and safe, but high-quality evidence from large-scale studies in atherosclerotic renal artery stenosis remains limited.
This study aims to evaluate whether covered stents are more effective than bare metal stents in patients with atherosclerotic renal artery stenosis. Eligible participants will be randomly assigned to receive either a covered stent or a bare metal stent. Patients will be followed for 12 months to assess Changes in eGFR, 24-hour systolic blood pressure, and 24-hour diastolic blood pressure from baseline to 12 months were compared among the groups.
The results of this study may help improve treatment strategies and guide the selection of stent type for patients with this condition.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Xiongjing Jiang
- 电话号码:86-010-88322387
- 邮箱:jiangxiongjing@163.com
研究联系人备份
- 姓名:Hui Dong
- 电话号码:86-010-88322385
- 邮箱:donghui666@sina.com
学习地点
-
-
-
Beijing、中国
- Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037
-
接触:
- Hui Dong
- 电话号码:15810161393
- 邮箱:donghui666@sina.com
-
Chongqing、中国、400016
- Department of Cardiovascular Medicine, Cardiovascular Research Center , The First Affiliated Hospital of Chongqing Medical University
-
Harbin、中国
- The Second Affiliated Hospital of Harbin Medical University, Ha'erbin
-
接触:
- Shuo Zhang
- 电话号码:18645056661
- 邮箱:zhangshuoemail@163.com
-
Jilin、中国、130033
- China-Japan Union Hospital of Jilin University, Changchun, Lilin
-
接触:
- Yuquan He
- 电话号码:13944145413
- 邮箱:liuxueyan@jlu.edu.cn
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510000
- The First Affiliated Hospital of Sun Yat-sen University
-
接触:
- Wenhao Xia
- 电话号码:020-87755766
- 邮箱:xiawhao@mail.sysu.edu.cn
-
-
Heilongjiang
-
Harbin、Heilongjiang、中国、150086
- The Second Affiliated Hospital of Harbin Medical University
-
接触:
- Zhiyu Shi
- 电话号码:18645056661
- 邮箱:zhangshuoemail@163.com
-
-
Henan
-
Zhengzhou、Henan、中国、450000
- Fuwai Central China Cardiovascular Hospital
-
Zhengzhou、Henan、中国、450007
- Zhengzhou Central Hospital Affiliated to Zhengzhou University
-
接触:
- Shuhua Yu
- 电话号码:0371-67690941
- 邮箱:13613716677@139.com
-
-
Jiangsu
-
Nanjing、Jiangsu、中国、211800
- Nanjing Pukou People's Hospital(Liangjiang Hospital Southeast University)
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330038
- Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
-
-
Liaoning
-
Dalian、Liaoning、中国、116001
- Affilated Zhongshan Hospital of Dalian University
-
Dalian、Liaoning、中国
- Frist Aiffiliated Hospital of Dalian Medical University
-
-
Shandong
-
Jinan、Shandong、中国、250012
- Qilu Hospital of Shandong University
-
Qingdao、Shandong、中国
- Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
-
-
Sichuan
-
Chengdu、Sichuan、中国、610031
- The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu
-
接触:
- Zhen Zhang
- 电话号码:13708042927
- 邮箱:31350377@qq.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- 1) Renal artery diameter stenosis ≥60%; 2) Office systolic blood pressure ≥ 160 mmHg and/or office diastolic blood pressure ≥ 100 mmHg on at least two separate days without antihypertensive medication, or office systolic blood pressure ≥ 140 mmHg and/or office diastolic blood pressure ≥ 90 mmHg while on three antihypertensive drugs at conventional doses; 3) Serum creatinine < 264 μmol/L (3.0 mg/dL); 4) Affected kidney length ≥ 7.0 cm, with residual glomerular filtration rate (GFR) ≥ 10 mL/min;
Exclusion Criteria:
- 1) Unstable clinical condition rendering the patient intolerant to revascularisation therapy; 2) Urinary protein ≥2+; 3) Contrast medium allergy; 4) Renal artery anatomy unsuitable for revascularisation therapy; 5) Reference vessel diameter <3.5mm or >8mm. 6)Patients with non-atherosclerotic renal artery stenosis (such as fibromuscular dysplasia or Takayasu arteritis); 7)Reference vessel diameter < 3.5 mm or > 8 mm
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:bare metal stents group
|
Endovascular implantation of a bare metal stent in the renal artery.
|
|
实验性的:covered stents group
|
Endovascular implantation of a covered stent in the renal artery
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in eGFR
大体时间:12 months
|
Change in estimated glomerular filtration rate (eGFR) at 12 months compared with baseline
|
12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in 24-Hour Ambulatory Systolic Blood Pressure
大体时间:12 months
|
Change in 24-Hour Ambulatory Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in 24-Hour Ambulatory Diastolic Blood Pressure
大体时间:12 months
|
Change in 24-Hour Ambulatory Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Office Systolic Blood Pressure
大体时间:12 months
|
Change in Office Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Office Diastolic Blood Pressure
大体时间:12 months
|
Change in Office Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Home Systolic Blood Pressure
大体时间:12 months
|
Change in Home Systolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in Home Diastolic Blood Pressure
大体时间:12 months
|
Change in Home Diastolic Blood Pressure Compared With Baseline
|
12 months
|
|
Change in antihypertensive medication burden
大体时间:12 months
|
Change in antihypertensive medication burden at 12 months compared with pre-procedure levels
|
12 months
|
|
Stent patency
大体时间:12 months
|
Stent patency at 12 months
|
12 months
|
|
Incidence of perioperative complications
大体时间:1 month
|
1 month
|
|
|
MACE
大体时间:12 months
|
Major adverse cardiovascular events (MACE) include cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure.
|
12 months
|
|
Renal Adverse Events
大体时间:12 months
|
Renal adverse events include a sustained decline in renal function (≥30% decrease in eGFR from baseline confirmed on repeat measurement), doubling of serum creatinine, initiation of renal replacement therapy (dialysis or kidney transplantation), or progression to end-stage renal disease.
|
12 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2026-0427
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.